Biomarker Testing in Non-Small Cell Lung Cancer A Clinician's Perspective

被引：5
|
作者：
Bernicker, Eric [1 ]
机构：
[1] Houston Methodist Hosp, Thorac Med Oncol, Houston, TX 77030 USA
来源：
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE | 2015年 / 139卷 / 04期
关键词：
PHASE-II TRIAL; 1ST-LINE TREATMENT; OPEN-LABEL; EGFR; CHEMOTHERAPY; MUTATIONS; ERLOTINIB; CARBOPLATIN; COMBINATION; PACLITAXEL;
D O I：
10.5858/arpa.2014-0085-ED
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：448 / 450
页数：3
相关论文
共 50 条
  • [41] Genetic testing for chemotherapy in non-small cell lung cancer
    Rosell, R
    Taron, M
    Alberola, V
    Massuti, B
    Felip, E
    LUNG CANCER, 2003, 41 : S97 - S102
  • [42] Biomarker Testing in Non-Small Cell Lung Carcinoma: Performance and Patient Outcomes
    Fadel, Saleh
    Chirip, Venus
    Wheatley-Price, Paul
    Reaume, Neil
    Lo, Bryan
    Chang, Nina
    Sekhon, Harmanjatinder
    Gomes, Marcio
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 1103 - 1104
  • [43] BIOMARKER UPDATE FOR BREAST, COLORECTAL AND NON-SMALL CELL LUNG CANCER
    Ross, Jeffrey S.
    DRUG NEWS & PERSPECTIVES, 2010, 23 (01) : 82 - 88
  • [44] Predictive biomarker analysis of non-small cell lung cancer patients
    Sakellariou, S.
    Karatrasoglou, E. A.
    Chatziandreou, I.
    Giannopoulou, I.
    Michelli, M.
    Zougros, A.
    Rouppou, E.
    Stamopoulos, K.
    Lazaris, A. C.
    Korkolopoulou, P.
    Saetta, A.
    VIRCHOWS ARCHIV, 2019, 475 : S105 - S105
  • [45] Patient and Clinician Preferences for Genetic and Genomic Testing in Non-Small Cell Lung Cancer: A Discrete Choice Experiment
    Fifer, Simon
    Ordman, Robyn
    Briggs, Lisa
    Cowley, Andrea
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (06):
  • [46] Biomarker Testing for Non-Small Cell Lung Cancer at a Tertiary Referral Hospital in Ireland: Challenges and Opportunities
    Bredin, P.
    Breathnach, O.
    O'Brien, E.
    Morgan, R.
    Sulaiman, I.
    Redmond, M.
    Higgins, C.
    Doyle, B.
    Naidoo, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1157 - S1158
  • [47] Non-small cell lung cancer predictive biomarker testing via immunocytochemistry: Ways of future past?
    VanderLaan, Paul A.
    CANCER CYTOPATHOLOGY, 2019, 127 (05) : 278 - 280
  • [48] Racial disparities in biomarker testing and clinical trial enrollment in non-small cell lung cancer (NSCLC).
    Bruno, Debora S.
    Hess, Lisa M.
    Li, Xiaohong
    Su, Eric Wen
    Zhu, Yajun Emily
    Patel, Monaliben
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [49] Biomarker testing in patients with advanced non-small cell lung cancer: the never-ending story
    Malapelle, Umberto
    Novello, Silvia
    LANCET REGIONAL HEALTH-EUROPE, 2024, 38
  • [50] Predictors of biomarker testing among patients (pts) with metastatic non-small cell lung cancer (mNSCLC).
    Robert, Nicholas J.
    Chen, Liwei
    Espirito, Janet L.
    Karhade, Mandar
    Evangelist, Makenzi Colleen
    Neubauer, Marcus A.
    Bullock, Susie A.
    Walberg, Jennifer M.
    Coleman, Robert L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345